AAIC 2025 Abstract·26 DecBlood‐based biomarkers enrich for amyloid positive participants, reducing patient burden in PROGRESS‐AD, a phase 2 clinical trial for early Alzheimer's diseaseTrial in peopleBiomarkersPaper